Atara Biotherapeutics Inc (0HIY.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
1280 Rancho Conejo Blvd
Thousand Oaks, CA 91320
United States of America (the)
Phone
650 278 8930
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
14
First IPO Date
January 29, 2018
| Name | Title | Pay | Year Born |
| Anhco Nguyen | President, Chief Executive Officer & Director | 1.07M | 1973 |
| Jim Sesic | Senior Vice President of Regulatory Affairs | 0 | N/A |
| John Chao | Head of Legal | 0 | N/A |
| Yanina Grant-Huerta | Chief Accounting Officer & Principal Accounting Officer | 0 | 1978 |
| Alex Chapman | Vice President of Corporate Communications & Investor Relations | 0 | N/A |
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.